From: Predictive value of serum testosterone for type 2 diabetes risk assessment in men
 | Raw data | Raw data | Raw data |
---|---|---|---|
Serum total testosterone cut-off points | Sensitivity, % (95Â % CI) | Specificity, % (95Â % CI) | Positive predictive value, % (95Â % CI) |
<10 vs ≥10 | 16.1 (10.5,23.5) | 93.4 (91.9,94.6) | 19.6 (13.0,28.4) |
<11 vs ≥11 | 24.1 (17.4,32.3) | 89.0 (87.2,90.6) | 18.0 (12.9,24.5) |
<12 vs ≥12 | 28.5 (21.3,36.9) | 83.8 (81.8,85.7) | 15.1 (11.0,20.1) |
<13 vs ≥13 | 37.2 (29.2,45.9) | 77.9 (75.6,80.1) | 14.4 (11.1,18.7) |
<14 vs ≥14 | 44.5 (36.1,53.2) | 71.4 (68.9,73.8) | 13.6 (10.6,17.1) |
<15 vs ≥15 | 54.7 (46.0,63.2) | 65.6 (63.0,68.1) | 13.8 (11.0,17.0) |
<16 vs ≥16 | 61.3 (52.6,69.4) | 58.3 (55.6,60.9) | 12.9 (10.4,15.8) |
<17 vs ≥17 | 68.6 (60.0,76.1) | 51.2 (48.6,53.9) | 12.4 (10.2,15.0) |
<18 vs ≥18 | 75.9 (67.7,82.6) | 43.5 (40.9,46.2) | 11.9 (9.9,14.3) |
<19 vs ≥19 | 80.3 (72.4,86.4) | 37.2 (34.7,39.9) | 11.4 (9.5,13.6) |
<20 vs ≥20 | 82.5 (74.9,88.2) | 31.3 (28.8,33.8) | 10.8 (9.0,12.8) |